Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphatic Diseases × enzalutamide × Clear all

Sponsor

Conditions

Prostatic Neoplasms 59 Breast Neoplasms 9 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 6 Neoplasms 4 Prostate Cancer Metastatic 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Metastatic Castration-resistant Prostate Cancer 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Metastatic Hormone Sensitive Prostate Cancer 2 Metastatic Castration Resistant Prostate Cancer 2 Melanoma 2 mCRPC 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ureteral Diseases 1 Small Cell Lung Carcinoma 1 Seizures 1 Salivary Cancer 1 Recurrent Endometrial Endometrioid Adenocarcinoma 1 Pancreatic Neoplasms 1 Neoplasms, Squamous Cell 1 Metastatic Progressive Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castrate-Resistant Prostate Cancer 1 Mesothelioma 1 Lymphoma, Mantle-Cell 1

Interventions

blinatumomab 5 Rituximab 3 Cyclophosphamide 3 Brentuximab Vedotin 3 ponatinib 2 Vincristine 2 Prednisone 2 Etoposide 2 Doxorubicin 2 tetulomab tetraxetan lu-177 1 ibritumomab tiuxetan 1 fludarabine 1 cobomarsen 1 Vorinostat 1 Melphalan 1 Lutetium 1 Imatinib Mesylate 1 Ifosfamide 1 Everolimus 1 Cytarabine 1 Carmustine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡